BJ-047

N/A

Report date: 2025/11/26 17:18:28

Base Information

Drug NameBJ-047
Drug Alias NameBJ-047BJ047
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-CD40 ligand
TargetsCD40 ligand
Therapy Area/IndicationsRejection of organ transplantationAutoimmune DiseasesLupus Nephritis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Bao Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Bao Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationAutoimmune DiseasesLupus Nephritis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A